Article History
Received: 4 January 2022
Accepted: 17 February 2022
First Online: 4 March 2022
Declarations
:
: Aurélie Ladang and Edgard Delvin declare no conflict of interest. Frank Rauch declare consulting or speaker fees for Novartic Inc, Ultragenyx Inc, and Sanofi Inc. Etienne Cavalier is consultant for IDS, DiaSorin, Fujirebio, Nittobo, bioMérieux, and Werfen.